General Atlantic
General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Their healthcare practice invests in life sciences, healthcare services, and healthcare technology companies at the growth stage, with a focus on transformative businesses.
Location
New York, New York, USA
Founded
1980
AUM
$84B+
Investment Range
$100M - $1B+
Portfolio Companies
1
Focus
pe
Fund Stages
growth
Investment Thesis
General Atlantic focuses on growth-stage investments in healthcare companies that are transforming their industries through technology and innovation. They target companies with proven business models seeking capital to scale globally, typically investing $100M+ in late-stage rounds.
Team
Partners / Managing Directors (Health & Bio Focus)
- Robbert Vorhoff - Managing Director, Healthcare
- Anton Levy - Co-President & Managing Director
- Martín Escobari - Co-President & Managing Director
Other Key Team Members
- Jeff Klinger - Vice President, Healthcare
Focus Areas
- Healthcare technology
- Life sciences
- Healthcare services
- Precision medicine
- Digital health
- Biopharma services
Notable Exits
- Veracyte - Public company (diagnostics)
- Livongo - Acquired by Teladoc (2020, $18.5B)
- Alignment Healthcare - IPO (2021)
Sources
- https://www.generalatlantic.com
- https://www.generalatlantic.com/team
- PitchBook
- Crunchbase
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Ultima Genomics | Fremont, California, USA | 2016 | genomics-sequencingbiotech+1 |